Article
[Therapy of hepatitis C].
Praxis - 29 May 2002
Moradpour D, Blum H E
Abstract excerpt
Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Here, we will briefly review current and evolving therapies for chronic hepatitis C. Standard therapy with (pegylated) interferon-alpha and ribavirin achieves sustained response rates of up to about 40% in genotype 1- and about 80% in genotype 2- and 3-infected patients. Recent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
